Skip to main content

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

The Original Article was published on 11 December 2020

Correction to: J Hematol Oncol (2020) 13:173 https://doi.org/10.1186/s13045-020-01007-9

The original article contains an incorrect affiliation for co-author, Meike Vogler. The correct affiliation can be viewed in this Correction article.

Reference

  1. Bolomsky A, et al. MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol. 2020;13:173. https://doi.org/10.1186/s13045-020-01007-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jo Caers.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolomsky, A., Vogler, M., Köse, M.C. et al. Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol 14, 31 (2021). https://doi.org/10.1186/s13045-021-01043-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-021-01043-z